
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Semiconductor metrology and energy research orders surge over 50% organically.
Moby summary of Bruker Corporation's Q2 2026 earnings call
Bruker Corp (BRKR) posts 5.2% revenue growth and 53% EPS jump, driven by strong biopharma and semiconductor orders despite U.S. academic weakness.
Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue
Bruker (BRKR) delivered earnings and revenue surprises of +28.95% and -2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Scientific instrument company Bruker (NASDAQ:BRKR) will be announcing earnings results this Tuesday before market open. Here’s what to look for.
Bruker beats Q1 earnings and revenue estimates as Europe growth and strong BSI bookings offset margin pressure and softer organic sales.
Bruker (BRKR) delivered earnings and revenue surprises of +33.62% and +2.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.